BB Biotech AG (BBZA)
XETR
53.40
+20.00 (+59.88%)
Closed
Oct 7, 2026
Day's Range
52.6053.40
52 wk Range
33.4058.50
Financial Statements - BBZA - BB Biotech AG
Revenue
587.00M▲ 613.1%
Net Income
578.13M▲ 661.7%Net Margin 98.5%
Free Cash Flow
309.14M▲ 1.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 587M | 82.31M | -199.56M | -351.22M | -396.22M | 699.23M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 578.19M | 75.95M | -206.52M | -357.75M | -404.74M | 691.24M |
| Income Tax | 66K | 54K | 79K | 61K | 67K | 75K |
| Net Income | 578.13M | 75.89M | -206.60M | -357.81M | -404.80M | 691.17M |
| EPS Basic | 10.54 | 1.38 | -3.77 | -6.5 | -7.31 | 12.48 |
| EPS Diluted | 10.54 | 1.38 | -3.77 | -6.5 | -7.31 | 12.48 |
| Basic Shares Outstanding | 54.84M | 54.83M | 54.84M | 51.68M | 52.01M | 52.04M |
| Diluted Shares Outstanding | 54.84M | 54.83M | 54.84M | 51.68M | 52.01M | 52.04M |
| Ebit | - | - | - | - | - | - |
| Ebitda | - | - | - | - | - | - |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
